TIW
Showing 1 - 25 of 160
Tuberculosis, Multidrug-Resistant, Tuberculosis, Tuberculosis, Pulmonary Trial in Worldwide (Linezolid 600 mg, Linezolid 1200 mg
Recruiting
- Tuberculosis, Multidrug-Resistant
- +2 more
- Linezolid 600 mg
- +7 more
-
Gaborone, South-East District, Botswana
- +16 more
Dec 13, 2022
Anemia, Dialysis-dependent Chronic Kidney Disease Trial in United States (Vadadustat, Epoetin Alfa, Vadadustat TIW)
Completed
- Anemia
- Dialysis-dependent Chronic Kidney Disease
- Vadadustat
- +2 more
-
Fresno, California
- +40 more
Sep 1, 2022
Chronic Kidney Disease, Anemia Trial in United States (Roxadustat, Placebo)
Metastatic Breast Cancer Trial in Beijing (Vinorelbine 40mg, Toripalimab 240mg, Bevacizumab 5 mg/kg)
Recruiting
- Metastatic Breast Cancer
- Vinorelbine 40mg
- +5 more
-
Beijing, Beijing, China
- +1 more
Feb 9, 2022
Acute Kidney Injury Trial in San Francisco (Conservative dialysis strategy, TIW dialysis strategy)
Terminated
- Acute Kidney Injury
- Conservative dialysis strategy
- TIW dialysis strategy
-
San Francisco, CaliforniaUCSF Medical Center Moffitt-Long Hospital
Nov 14, 2019
Hemophilia A With Inhibitor Trial (SCT800 and Daratumumab)
Not yet recruiting
- Hemophilia A With Inhibitor
- SCT800 and Daratumumab
- (no location specified)
May 24, 2023
Assess Adherence to Treatment for Patients With RMS (MAIN-MS)
Completed
- Relapsing Multiple Sclerosis (RMS)
- Rebif (Interferon beta-1a)
-
Alger, Algeria
- +40 more
Mar 22, 2022
Anemia Associated With Chronic Kidney Disease (CKD) Trial in United States (Vadadustat, Mircera®)
Active, not recruiting
- Anemia Associated With Chronic Kidney Disease (CKD)
-
Huntsville, Alabama
- +57 more
Jan 31, 2022
Chemo-induced Peripheral Neuropathy (CIPN) Trial (SON-080)
Not yet recruiting
- Chemotherapy-induced Peripheral Neuropathy (CIPN)
- SON-080
- (no location specified)
Jun 23, 2022
Anemia, End Stage Renal Disease Trial in United States (AKB-6548)
Completed
- Anemia
- End Stage Renal Disease
-
El Granada, California
- +15 more
Jun 7, 2022
Chronic Kidney Disease, Anemia Trial in Puerto Rico, United States (Roxadustat)
Completed
- Chronic Kidney Disease
- Anemia
-
Mobile, Alabama
- +37 more
Jan 17, 2022
Pulmonary TB Trial in South Africa (Delamanid + Bedaquiline + OPC-167832 10 mg, Delamanid + Bedaquiline + OPC-167832 30 mg,
Recruiting
- Pulmonary TB
- Delamanid + Bedaquiline + OPC-167832 10 mg
- +3 more
-
Tembisa, Gauteng, South Africa
- +7 more
Jun 30, 2022
End Stage Renal Disease, Anemia Trial in United States (Roxadustat, Epoetin Alfa, Placebo)
Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts) Trial in Worldwide (FG-4592, Placebo)
Active, not recruiting
- Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)
- Roxadustat
- Placebo
-
Los Angeles, California
- +71 more
Sep 16, 2022
Multiple Myeloma Trial in Worldwide (panobinostat capsules, bortezomib injection, dexamethasone tablets)
Active, not recruiting
- Multiple Myeloma
- panobinostat capsules
- +2 more
-
Fayetteville, Arkansas
- +79 more
Mar 15, 2021
Leprosy, Multibacillary Trial in Bauru, Manaus (Bedaquiline 200 mg)
Active, not recruiting
- Leprosy, Multibacillary
- Bedaquiline 200 mg
-
Bauru, Brazil
- +1 more
Aug 2, 2022
Diabetic Foot Ulcer, Pseudomonas Aeruginosa Infection, Staphylococcus Aureus Infection Trial in Jerusalem, Tel Aviv (TP-102)
Recruiting
- Diabetic Foot Ulcer
- +3 more
- TP-102
-
Jerusalem, Israel
- +1 more
Jun 17, 2022
Head and Neck Carcinoma Trial in Houston (LORETA Neurofeedback Training, Questionnaire Administration)
Active, not recruiting
- Head and Neck Carcinoma
- LORETA Neurofeedback Training
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Multiple Sclerosis, Relapsing-Remitting Trial in Italy (dietary supplement, drug, biological)
Terminated
- Multiple Sclerosis, Relapsing-Remitting
- D-aspartate
- +3 more
-
Cagliari, Italy
- +16 more
Feb 6, 2020